251 related articles for article (PubMed ID: 11455677)
1. Pharmacokinetics of menthol and carvone after administration of an enteric coated formulation containing peppermint oil and caraway oil.
Mascher H; Kikuta C; Schiel H
Arzneimittelforschung; 2001; 51(6):465-9. PubMed ID: 11455677
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of carvone and menthol after administration of peppermint oil and caraway oil containing enteric formulation].
Mascher H; Kikuta Ch; Schiel H
Wien Med Wochenschr; 2002; 152(15-16):432-6. PubMed ID: 12244893
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence evaluation of menthol after oral administration of peppermint oil soft capsules in dogs.
Wu JF; Xiang BR; Li KX
Arzneimittelforschung; 2010; 60(8):479-82. PubMed ID: 20863003
[TBL] [Abstract][Full Text] [Related]
4. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
[TBL] [Abstract][Full Text] [Related]
5. [Peppermint oil-caraway oil fixed combination in non-ulcer dyspepsia--comparison of the effects of enteric preparations].
Freise J; Köhler S
Pharmazie; 1999 Mar; 54(3):210-5. PubMed ID: 10192108
[TBL] [Abstract][Full Text] [Related]
6. Effects of peppermint oil and caraway oil on gastroduodenal motility.
Micklefield GH; Greving I; May B
Phytother Res; 2000 Feb; 14(1):20-3. PubMed ID: 10641042
[TBL] [Abstract][Full Text] [Related]
7. Effects of intraduodenal application of peppermint oil (WS(R) 1340) and caraway oil (WS(R) 1520) on gastroduodenal motility in healthy volunteers.
Micklefield G; Jung O; Greving I; May B
Phytother Res; 2003 Feb; 17(2):135-40. PubMed ID: 12601675
[TBL] [Abstract][Full Text] [Related]
8. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
Walter K; von Nieciecki A
Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
10. [The relative bioavailability and pharmacokinetics of standardized myrtol].
Zimmermann T; Seiberling M; Thomann P; Karabelnik D
Arzneimittelforschung; 1995 Nov; 45(11):1198-201. PubMed ID: 8929239
[TBL] [Abstract][Full Text] [Related]
11. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
Bonn M; Eydeler U; Barkworth M; Rovati LC
Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia.
May B; Kuntz HD; Kieser M; Köhler S
Arzneimittelforschung; 1996 Dec; 46(12):1149-53. PubMed ID: 9006790
[TBL] [Abstract][Full Text] [Related]
14. Is it possible to achieve bio-equivalence between an oral solid immediate-release and an analogue enteric-coated formulation?
Licht D; Cohen R; Spiegelstein O; Rabinovich-Guilatt L; Zholkovsky M; Gilbert A; Dressman JB; Safadi M
J Pharm Pharmacol; 2016 Oct; 68(10):1278-89. PubMed ID: 27465906
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
Walter K; Weiss G; Laicher A; Stanislaus F
Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
[TBL] [Abstract][Full Text] [Related]
17. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.
Dresser GK; Wacher V; Wong S; Wong HT; Bailey DG
Clin Pharmacol Ther; 2002 Sep; 72(3):247-55. PubMed ID: 12235445
[TBL] [Abstract][Full Text] [Related]
19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
20. A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.
Weerts ZZRM; Keszthelyi D; Vork L; Aendekerk NCP; Frijlink HW; Brouwers JRBJ; Neef C; Jonkers DMAE; Masclee AAM
Adv Ther; 2018 Nov; 35(11):1965-1978. PubMed ID: 30284674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
